FATE vs NFLX · rev $3.4M vs P/E 25, rev $12.56B
Fate Therapeutics Inc (FATE) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ. It is led by Ted Sarandos.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
FATE currently screens at market cap $331.0M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the FATE and NFLX stock pages for the full models.
Not investment advice.